Robert Langer
Angel · Massachusetts
Board director at 10 startups that filed Form D raises since late 2024, mostly in Massachusetts.
- Stages
- Pre-seed to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Aug 2025
Focus
Biotech & PharmaRecent portfolio activity
- Aug 2025
VitaKey
Board seat · NC
- Jan 2025
Syntis BIO
Board seat · MA
- Jan 2024
Omnipulse Biosciences
Board seat · MA
- Dec 2023
Teal Bio
Board seat · MA
- Aug 2023
Suono Bio
Board seat · MA
- Aug 2023
Noveome Biotherapeutics
Board seat · PA
- Aug 2023
Bilayer Therapeutics
Board seat · MA
- Jun 2023
Luminopia
Board seat · MA
- Jun 2023
Lyndra Therapeutics
Board seat · MA
- Jan 2023
Xenter
Board seat · UT
Sources
- SEC Form D: XenterJan 6, 2023
- SEC Form D: Syntis BIOJan 27, 2025
- SEC Form D: Teal BioDec 27, 2023
- SEC Form D: Lyndra TherapeuticsJun 7, 2023
- SEC Form D: LuminopiaJun 29, 2023
- SEC Form D: Bilayer TherapeuticsAug 4, 2023
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.